Bregni M - Search Results

1

High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.

Bregni M, Siena S, Ravagnani F, Bonadonna G, Gianni AM. Bregni M, et al. Haematologica. 1990 Jan-Feb;75 Suppl 1:95-8. Haematologica. 1990. PMID: 2190885 Clinical Trial.

2

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

Gianni AM, Bregni M, Siena S, Magni M, Di Nicola M, Lombardi F, Tarella C, Pileri A, Bonadonna G. Gianni AM, et al. Among authors: bregni m. J Clin Oncol. 1992 Dec;10(12):1955-62. doi: 10.1200/JCO.1992.10.12.1955. J Clin Oncol. 1992. PMID: 1280674

3

The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy.

Gianni AM, Siena S, Bregni M, Bonadonna G. Gianni AM, et al. Among authors: bregni m. Pathol Biol (Paris). 1992 Nov;39(9):956. Pathol Biol (Paris). 1992. PMID: 1347166 No abstract available.

4

Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.

Orazi A, Cattoretti G, Schiró R, Siena S, Bregni M, Di Nicola M, Gianni AM. Orazi A, et al. Among authors: bregni m. Blood. 1992 May 15;79(10):2610-9. Blood. 1992. PMID: 1586713 Free article.

5

Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.

Ravagnani F, Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Notti P, Pellegris G, Gianni AM. Ravagnani F, et al. Among authors: bregni m. Haematologica. 1991 Mar;76 Suppl 1:46-9. Haematologica. 1991. PMID: 1713874 Review.

6

Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.

Bregni M, Siena S, Magni M, Bonadonna G, Gianni AM. Bregni M, et al. Leukemia. 1991;5 Suppl 1:123-7. Leukemia. 1991. PMID: 1716335 No abstract available.

7

Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.

Gianni AM, Siena S, Bregni M, Lombardi F, Gandola L, Valagussa P, Bonadonna G. Gianni AM, et al. Among authors: bregni m. Ann Oncol. 1991 Oct;2(9):645-53. doi: 10.1093/oxfordjournals.annonc.a058043. Ann Oncol. 1991. PMID: 1720655 Free article.

8

Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies.

Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Bonadonna G, Gianni M. Siena S, et al. Among authors: bregni m. Haematologica. 1991 Jul-Aug;76(4):330-3. Haematologica. 1991. PMID: 1724439

9

[Clinical use of hematopoietic growth factors].

Gianni AM, Bregni M, Siena S, Tarella C, DiNicola M, Bonadonna G. Gianni AM, et al. Among authors: bregni m. Haematologica. 1991 Jun;76 Suppl 3:3-10. Haematologica. 1991. PMID: 1752526 Review. Italian. No abstract available.

10

Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF.

Tarella C, Ferrero D, Bregni M, Siena S, Gallo E, Pileri A, Gianni AM. Tarella C, et al. Among authors: bregni m. Eur J Cancer. 1991;27(1):22-7. doi: 10.1016/0277-5379(91)90052-f. Eur J Cancer. 1991. PMID: 1826435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters